| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | 1,3,7-15N3, 98%), CP 95%+ Basic information |
| Product Name: | 1,3,7-15N3, 98%), CP 95%+ | | Synonyms: | URIC ACID (2-13C, 98%;1,3,7-15N3, 98%), CP 95%+;15N3]-Uric Acid;1,3,7-1?N?, 98%) CP 95%;Uric acid (2-13C, 98%;Uric Acid-13C,15N3 (Standard) | | CAS: | 2421217-23-2 | | MF: | C5H4N4O3 | | MW: | 172.08 | | EINECS: | | | Product Categories: | | | Mol File: | 2421217-23-2.mol |  |
| | 1,3,7-15N3, 98%), CP 95%+ Chemical Properties |
| density | 1.873±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | form | Solid | | color | White to off-white | | CAS Number Unlabeled | 69-93-2 |
| | 1,3,7-15N3, 98%), CP 95%+ Usage And Synthesis |
| Uses | Uric acid-13C,15N3 is the 13C-labeled and 15N-labeled Uric acid. Uric acid, scavenger of oxygen radical, is a very important antioxidant that help maintains the stability of blood pressure and antioxidant stress. Uric acid can remove reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, inhibiting lipid peroxidation[1][2]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Wang Q, et al. Recent Progress on Uric Acid Detection: A Review. Crit Rev Anal Chem. 2020;50(4):359-375. DOI:10.1080/10408347.2019.1637711
[3] Yasutake Y, et al. Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity. J Gastroenterol Hepatol. 2017 Nov;32(11):1839-1845. DOI:10.1111/jgh.13785 |
| | 1,3,7-15N3, 98%), CP 95%+ Preparation Products And Raw materials |
|